Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Surmodics Inc's Business Segments
Surmodics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q3 FY2025
Reportable Segments
2
Largest Segment
Medical Device
Total Revenue
$ 30
Regions Reported
-
Revenue Share by Reportable Segment - Q3 FY2025
- Medical Device75.1%
- In Vitro Diagnostics24.9%
Revenue by Reportable Segment - Q3 FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Medical Device | $ 22 | 75.1% |
| In Vitro Diagnostics | $ 7 | 24.9% |
Revenue by Product & Service Category - Q3 FY2025
- Royalty32.7%
- Product24.4%
- Research Development and Other0.4%
Revenue by Product & Service Category - Q3 FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Royalty | $ 10 | 32.7% |
| Product | $ 7 | 24.4% |
| Research Development and Other | $ 0 | 0.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Surmodics Inc
Surmodics Inc is a medical technology company that designs, manufactures, and markets a range of products focused on enhancing the performance of medical devices. Founded in 1979 and headquartered in Eden Prairie, Minnesota, the company has its presence in more than 80 countries worldwide. Surmodics works closely with its customers and partners to develop innovative solutions to address the critical needs in the medical community.
The company's product portfolio includes surface modification coatings, drug delivery coatings, hydrophilic coatings, antimicrobial coatings, and other related technologies. These coatings are designed to improve the performance of medical devices, such as catheters, stents, drug-eluting balloons, and diagnostic systems. Surmodics' products are used in a wide range of medical specialties, including cardiology, ophthalmology, and neurology.
Surmodics operates through two business segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment involves developing, manufacturing, and selling medical device technologies, while the IVD segment involves developing, manufacturing, and selling diagnostic tests and equipment. While the Medical Device segment constitutes the majority of the company's revenue, the IVD segment offers healthy growth opportunities for the future.
Surmodics is known for its research and development capabilities, and the company invests heavily in R&D to develop new products and technologies. The company has a dedicated team of scientists and engineers who work on new ideas and projects that can be commercialized into innovative, market-leading products. The company also collaborates with leading medical device companies and academic institutions to advance its research and development capabilities.
One of Surmodics' key strengths lies in its ability to provide customized solutions to customers. The company offers co-development services, where it collaborates with customers to design and develop products that meet their specific needs. Additionally, Surmodics' experienced sales and marketing team works closely with customers to identify new market opportunities and develop customized marketing strategies.
The company's financials are strong, with steady revenue growth and profitability. The company generates the majority of its revenue from the United States, but it has a growing international presence. Surmodics' conservative balance sheet and low debt make it well-positioned to invest in new products and opportunities.
In conclusion, Surmodics Inc is a medical technology company that specializes in developing, manufacturing, and selling products that enhance the performance of medical devices. With a strong focus on R&D, market-leading products, and customer collaboration, Surmodics is well positioned to continue its growth and success in the medical technology industry.
The company's product portfolio includes surface modification coatings, drug delivery coatings, hydrophilic coatings, antimicrobial coatings, and other related technologies. These coatings are designed to improve the performance of medical devices, such as catheters, stents, drug-eluting balloons, and diagnostic systems. Surmodics' products are used in a wide range of medical specialties, including cardiology, ophthalmology, and neurology.
Surmodics operates through two business segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment involves developing, manufacturing, and selling medical device technologies, while the IVD segment involves developing, manufacturing, and selling diagnostic tests and equipment. While the Medical Device segment constitutes the majority of the company's revenue, the IVD segment offers healthy growth opportunities for the future.
Surmodics is known for its research and development capabilities, and the company invests heavily in R&D to develop new products and technologies. The company has a dedicated team of scientists and engineers who work on new ideas and projects that can be commercialized into innovative, market-leading products. The company also collaborates with leading medical device companies and academic institutions to advance its research and development capabilities.
One of Surmodics' key strengths lies in its ability to provide customized solutions to customers. The company offers co-development services, where it collaborates with customers to design and develop products that meet their specific needs. Additionally, Surmodics' experienced sales and marketing team works closely with customers to identify new market opportunities and develop customized marketing strategies.
The company's financials are strong, with steady revenue growth and profitability. The company generates the majority of its revenue from the United States, but it has a growing international presence. Surmodics' conservative balance sheet and low debt make it well-positioned to invest in new products and opportunities.
In conclusion, Surmodics Inc is a medical technology company that specializes in developing, manufacturing, and selling products that enhance the performance of medical devices. With a strong focus on R&D, market-leading products, and customer collaboration, Surmodics is well positioned to continue its growth and success in the medical technology industry.
Surmodics, Inc. is a prominent publicly-traded medical device company headquartered in Eden Prairie, Minnesota. The company is dedicated to advancing medical technologies in various markets, including interventional cardiology, neurovascular, peripheral vascular, and structural heart applications. Surmodics operates through two primary segments: Medical Devices and In Vitro Diagnostics, each offering a comprehensive portfolio of products and services aimed at improving patient outcomes.
Segments
1. Medical Devices
This segment is focused on the development and manufacturing of devices designed for minimally invasive medical procedures. Surmodics has established a robust lineup of innovative products, each tailored to meet the needs of healthcare professionals and enhance procedural efficacy. The key offerings in this segment include:
- Balloon Catheters: Surmodics produces various balloon catheters engineered for vascular interventions. These devices are designed for improved control and visibility during angioplasty, which is critical in treating obstructed arteries.
- Embolization Coils: The company manufactures embolization coils utilized for the treatment of aneurysms, vascular malformations, and hemorrhagic conditions. These coils play a crucial role in occluding abnormal blood vessels to prevent further complications.
- Delivery Systems: Surmodics provides sophisticated delivery systems for drug-coated balloons and stents, encompassing both rapid-exchange and over-the-wire configurations. These systems facilitate the accurate placement of therapeutic devices within the vascular system.
- Imaging Agents: The company offers microbubbles and contrast media designed to enhance the visualization of blood vessels during imaging procedures. This is essential for effective diagnostics and further interventional planning.
In Vitro Diagnostics
This segment develops reagents for diagnostic procedures, contributing to the rapid and accurate detection of various disease states. The offerings include:
- Disease State Markers: Surmodics provides markers that assist in diagnosing conditions such as cancer, infectious diseases, and autoimmune disorders, allowing for timely and effective treatment decisions.
- IVD OEM Components: The company develops components for in vitro diagnostic tests, including antibodies, proteins, and polymers. These components are critical for ensuring the reliability and accuracy of diagnostic testing.
Products
Surmodics boasts a diverse range of medical devices and in vitro diagnostics products, including:
Medical Devices
- Pouncee Catheter: This rapid exchange balloon catheter is designed for quick access to target lesions, enhancing the efficiency of vascular interventions.
- Serenee Microcatheter: Tailored for both neurovascular and peripheral vascular applications, this microcatheter provides precise control and optimal navigation during procedures.
- Sundancee Balloon Catheter: A low-profile balloon catheter that navigates difficult-to-reach areas of the vasculature, facilitating complex interventions.
- Traxione Microcatheter: A pushable microcatheter expertly engineered for the delivery of embolic devices, critical in achieving therapeutic outcomes in vascular occlusions.
- Avesse Delivery System: A rapid exchange drug-coated balloon catheter specifically designed to treat patients with peripheral artery disease, promoting better blood flow and reducing symptoms.
In Vitro Diagnostics
- StabilZymee Protein Stabilizing Technology: This line of protein stabilizers enhances the sensitivity and accuracy of diagnostic tests, ensuring reliable results.
- Empowerede Capillary Coatings: These coatings are utilized to improve the separation and detection of proteins from complex biological samples, aiding in diagnostic efficacy.
- KPLe Reagents: A high-quality range of reagents that support various in vitro diagnostic tests, including immunoassays and molecular diagnostics, enhancing the detection of diverse medical conditions.
Services
In addition to its product offerings, Surmodics provides a comprehensive suite of services aimed at enhancing the development and commercialization of medical devices and diagnostic products:
- Coating Services: Surmodics offers specialized coating solutions for catheters, balloons, and other medical devices. These proprietary coatings can significantly enhance performance characteristics and therapeutic outcomes.
- Analytical Services: The company provides extensive analytical testing services, including surface characterization, extractibles and leachables testing, and biocompatibility assessments, ensuring that products meet stringent safety and quality standards.
- Design and Development Services: Surmodics supports partners through product design and development services, including custom catheter development and prototyping, essential for bringing innovative medical solutions to market.
Conclusion
Surmodics, Inc. stands out in the medical technology field with a strong emphasis on innovation and quality across its medical devices and in vitro diagnostics segments. Their broad array of products and supportive services not only enhance the capabilities of healthcare professionals but also significantly contribute to better patient outcomes across various medical disciplines. As the landscape of healthcare continues to evolve, Surmodics is well-positioned to play a pivotal role in advancing medical technologies.
Segments
1. Medical Devices
This segment is focused on the development and manufacturing of devices designed for minimally invasive medical procedures. Surmodics has established a robust lineup of innovative products, each tailored to meet the needs of healthcare professionals and enhance procedural efficacy. The key offerings in this segment include:
- Balloon Catheters: Surmodics produces various balloon catheters engineered for vascular interventions. These devices are designed for improved control and visibility during angioplasty, which is critical in treating obstructed arteries.
- Embolization Coils: The company manufactures embolization coils utilized for the treatment of aneurysms, vascular malformations, and hemorrhagic conditions. These coils play a crucial role in occluding abnormal blood vessels to prevent further complications.
- Delivery Systems: Surmodics provides sophisticated delivery systems for drug-coated balloons and stents, encompassing both rapid-exchange and over-the-wire configurations. These systems facilitate the accurate placement of therapeutic devices within the vascular system.
- Imaging Agents: The company offers microbubbles and contrast media designed to enhance the visualization of blood vessels during imaging procedures. This is essential for effective diagnostics and further interventional planning.
In Vitro Diagnostics
This segment develops reagents for diagnostic procedures, contributing to the rapid and accurate detection of various disease states. The offerings include:
- Disease State Markers: Surmodics provides markers that assist in diagnosing conditions such as cancer, infectious diseases, and autoimmune disorders, allowing for timely and effective treatment decisions.
- IVD OEM Components: The company develops components for in vitro diagnostic tests, including antibodies, proteins, and polymers. These components are critical for ensuring the reliability and accuracy of diagnostic testing.
Products
Surmodics boasts a diverse range of medical devices and in vitro diagnostics products, including:
Medical Devices
- Pouncee Catheter: This rapid exchange balloon catheter is designed for quick access to target lesions, enhancing the efficiency of vascular interventions.
- Serenee Microcatheter: Tailored for both neurovascular and peripheral vascular applications, this microcatheter provides precise control and optimal navigation during procedures.
- Sundancee Balloon Catheter: A low-profile balloon catheter that navigates difficult-to-reach areas of the vasculature, facilitating complex interventions.
- Traxione Microcatheter: A pushable microcatheter expertly engineered for the delivery of embolic devices, critical in achieving therapeutic outcomes in vascular occlusions.
- Avesse Delivery System: A rapid exchange drug-coated balloon catheter specifically designed to treat patients with peripheral artery disease, promoting better blood flow and reducing symptoms.
In Vitro Diagnostics
- StabilZymee Protein Stabilizing Technology: This line of protein stabilizers enhances the sensitivity and accuracy of diagnostic tests, ensuring reliable results.
- Empowerede Capillary Coatings: These coatings are utilized to improve the separation and detection of proteins from complex biological samples, aiding in diagnostic efficacy.
- KPLe Reagents: A high-quality range of reagents that support various in vitro diagnostic tests, including immunoassays and molecular diagnostics, enhancing the detection of diverse medical conditions.
Services
In addition to its product offerings, Surmodics provides a comprehensive suite of services aimed at enhancing the development and commercialization of medical devices and diagnostic products:
- Coating Services: Surmodics offers specialized coating solutions for catheters, balloons, and other medical devices. These proprietary coatings can significantly enhance performance characteristics and therapeutic outcomes.
- Analytical Services: The company provides extensive analytical testing services, including surface characterization, extractibles and leachables testing, and biocompatibility assessments, ensuring that products meet stringent safety and quality standards.
- Design and Development Services: Surmodics supports partners through product design and development services, including custom catheter development and prototyping, essential for bringing innovative medical solutions to market.
Conclusion
Surmodics, Inc. stands out in the medical technology field with a strong emphasis on innovation and quality across its medical devices and in vitro diagnostics segments. Their broad array of products and supportive services not only enhance the capabilities of healthcare professionals but also significantly contribute to better patient outcomes across various medical disciplines. As the landscape of healthcare continues to evolve, Surmodics is well-positioned to play a pivotal role in advancing medical technologies.